A conserved dendritic-cell regulatory program limits antitumour immunity
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A conserved dendritic-cell regulatory program limits antitumour immunity
Authors
Keywords
-
Journal
NATURE
Volume 580, Issue 7802, Pages 257-262
Publisher
Springer Science and Business Media LLC
Online
2020-03-26
DOI
10.1038/s41586-020-2134-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas
- (2019) Yoko Tsukita et al. Molecular Cancer
- Phenotype molding of stromal cells in the lung tumor microenvironment
- (2018) Diether Lambrechts et al. NATURE MEDICINE
- Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus–Derived Vectors Fosters Dendritic Cell–Mediated T-cell Cross-Priming
- (2018) Alfonso R. Sánchez-Paulete et al. CANCER RESEARCH
- High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy
- (2018) Matthew M. Gubin et al. CELL
- Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
- (2018) Christopher S. Garris et al. IMMUNITY
- Simultaneous epitope and transcriptome measurement in single cells
- (2017) Marlon Stoeckius et al. NATURE METHODS
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- TAM Receptor Signaling in Immune Homeostasis
- (2015) Carla V. Rothlin et al. Annual Review of Immunology
- Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors
- (2015) Franziska Paul et al. CELL
- The interaction of anticancer therapies with tumor-associated macrophages
- (2015) Alberto Mantovani et al. JOURNAL OF EXPERIMENTAL MEDICINE
- GFP-specific CD8 T cells enable targeted cell depletion and visualization of T-cell interactions
- (2015) Judith Agudo et al. NATURE BIOTECHNOLOGY
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- Massively Parallel Single-Cell RNA-Seq for Marker-Free Decomposition of Tissues into Cell Types
- (2014) D. A. Jaitin et al. SCIENCE
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- Cross-presenting CD103+ dendritic cells are protected from influenza virus infection
- (2012) Julie Helft et al. JOURNAL OF CLINICAL INVESTIGATION
- Deciphering the transcriptional network of the dendritic cell lineage
- (2012) Jennifer C Miller et al. NATURE IMMUNOLOGY
- Conditional Deletion of TGF-βR1 Using Langerin-Cre Mice Results in Langerhans Cell Deficiency and Reduced Contact Hypersensitivity
- (2011) Sonja P. Zahner et al. JOURNAL OF IMMUNOLOGY
- Response and Resistance to NF- B Inhibitors in Mouse Models of Lung Adenocarcinoma
- (2011) W. Xue et al. Cancer Discovery
- R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
- (2010) S. J. Holland et al. CANCER RESEARCH
- Mammalian Target of Rapamycin Controls Dendritic Cell Development Downstream of Flt3 Ligand Signaling
- (2010) Taheri Sathaliyawala et al. IMMUNITY
- The origin and development of nonlymphoid tissue CD103+DCs
- (2009) Florent Ginhoux et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started